| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |






From the Departments of Neurology and Neurosurgery* and Pathology,
McGill University, Montreal, Quebec; the Bloomfield Center for Research in Aging,
Lady Davis Institute for Medical Research, and the Department of Pathology,
Jewish General Hospital, Montreal, Quebec; and the Department of Laboratory Medicine and Pathobiology and Center for Research in Neurodegenerative Diseases,¶ University of Toronto, University of Toronto, Toronto, Canada
Previously, we have shown that caspase-6 but not caspase-3 is activated by serum deprivation and induces a protracted cell death in primary cultures of human neurons (LeBlanc AC, Liu H, Goodyer C, Bergeron C, Hammond J: Caspase-6 role in apoptosis of human neurons, amyloidogenesis and Alzheimers disease. J Biol Chem 1999, 274:2342623436 and Zhang Y, Goodyer C, LeBlanc A: Selective and protracted apoptosis in human primary neurons microinjected with active caspase-3, -6, -7, and -8. J Neurosci 2000, 20:83848389). Here, we show with neoepitope antibodies that the p20 subunit of active caspase-6 increases twofold to threefold in the affected temporal and frontal cortex but not in the unaffected cerebellum of Alzheimers disease brains and is present in neurofibrillary tangles, neuropil threads, and the neuritic plaques. Furthermore, a neoepitope antibody to caspase-6-cleaved Tau strongly detects intracellular tangles, extracellular tangles, pretangles, neuropil threads, and neuritic plaques. Immunoreactivity with both antibodies in pretangles indicates that the caspase-6 is active early in the pathogenesis of Alzheimers disease. In contrast to the nuclear and cytosolic localization of active caspase-6 in apoptotic neurons of fetal and adult ischemic brains, the active caspase-6 in Alzheimers disease brains is sequestered into the tangles or neurites. The localization of active caspase-6 may strongly jeopardize the structural integrity of the neuronal cytoskeletal system leading to inescapable neuronal dysfunction and eventual cell death in Alzheimers disease neurons. Our results suggest that active caspase-6 is strongly implicated in human neuronal degeneration and apoptosis.
This article has been cited by other articles:
![]() |
N. Louneva, J. W. Cohen, L.-Y. Han, K. Talbot, R. S. Wilson, D. A. Bennett, J. Q. Trojanowski, and S. E. Arnold Caspase-3 Is Enriched in Postsynaptic Densities and Increased in Alzheimer's Disease Am. J. Pathol., November 1, 2008; 173(5): 1488 - 1495. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-S. Yang, A. Kumar, P. Stavrides, J. Peterson, C. M. Peterhoff, M. Pawlik, E. Levy, A. M. Cataldo, and R. A. Nixon Neuronal Apoptosis and Autophagy Cross Talk in Aging PS/APP Mice, a Model of Alzheimer's Disease Am. J. Pathol., September 1, 2008; 173(3): 665 - 681. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Warby, C. N. Doty, R. K. Graham, J. B. Carroll, Y.-Z. Yang, R. R. Singaraja, C. M. Overall, and M. R. Hayden Activated caspase-6 and caspase-6-cleaved fragments of huntingtin specifically colocalize in the nucleus Hum. Mol. Genet., August 1, 2008; 17(15): 2390 - 2404. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Klaiman, T. L. Petzke, J. Hammond, and A. C. LeBlanc Targets of Caspase-6 Activity in Human Neurons and Alzheimer Disease Mol. Cell. Proteomics, August 1, 2008; 7(8): 1541 - 1555. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Albrecht, M. Bourdeau, D. Bennett, E. J. Mufson, M. Bhattacharjee, and A. C. LeBlanc Activation of Caspase-6 in Aging and Mild Cognitive Impairment Am. J. Pathol., April 1, 2007; 170(4): 1200 - 1209. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. E. Mouser, E. Head, K.-H. Ha, and T. T. Rohn Caspase-Mediated Cleavage of Glial Fibrillary Acidic Protein within Degenerating Astrocytes of the Alzheimer's Disease Brain Am. J. Pathol., March 1, 2006; 168(3): 936 - 946. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Cribbs, W. W. Poon, R. A. Rissman, and M. Blurton-Jones Caspase-Mediated Degeneration in Alzheimer's Disease Am. J. Pathol., August 1, 2004; 165(2): 353 - 355. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |